Tony Yao

Manufactures and markets biopharmaceuticals products

JHIUS offers US equity, global and international equity, fixed income, asset allocation and alternative investment strategies, including long-short portfolios. For their fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research. They utilize two complementary processes: a top-down macro analysis and a bottom-up risk/reward analysis.

Develops technology to produce custom, genome-editing enzymes for human health and biological research

Operates as a clinical-stage biotechnology company that develops T cell immunotherapies

Functions as a College/University

Functions as a College/University

ArrowMark uses fundamental research and an opportunistic investment philosophy when investing. They focus on niche and less efficient market segments in public and private credit and equity, leveraged loans, and middle-market commercial real estate finance. The firm primarily invests for relatively long-time horizons, often for a year or more.

Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions

ArrowMark Colorado Holdings /Private Equity/ seeks investment in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early and growth stage capital requirements.